Page last updated: 2024-09-02

11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and 2019 Novel Coronavirus Disease

11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kriikku, P; Mariottini, C; Ojanperä, I1

Other Studies

1 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and 2019 Novel Coronavirus Disease

ArticleYear
Increase in drugs-of-abuse findings in post-mortem toxicology due to COVID-19 restrictions-First observations in Finland.
    Drug testing and analysis, 2021, Volume: 13, Issue:4

    Topics: Amphetamine; Analgesics, Opioid; Autopsy; Buprenorphine; Cannabinoid Receptor Agonists; Central Nervous System Stimulants; COVID-19; Dronabinol; Finland; Forensic Toxicology; Harm Reduction; Humans; Illicit Drugs; Substance-Related Disorders

2021